Study of ONO-1101 in Patients Scheduled for Multi-Slice Computed Tomography (CT)

Last updated: June 12, 2012
Sponsor: Ono Pharmaceutical Co. Ltd
Overall Status: Completed

Phase

3

Condition

Myocardial Ischemia

Chest Pain

Atherosclerosis

Treatment

N/A

Clinical Study ID

NCT00924586
ONO-1101-27
  • Ages > 20
  • All Genders

Study Summary

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for multi-slice CT, in a double-blind, randomized, placebo-controlled, parallel group, multi-center study.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • ≥ 20 years old

  • Heart rate ≥ 70beats/min and ≤ 90beats/min at entering the CT room and just beforedosing organic nitrates.

Exclusion

Exclusion Criteria:

  • Previous allergic reactions to contrast agent

  • Renal failure

  • Asthma

Study Design

Total Participants: 258
Study Start date:
June 01, 2009
Estimated Completion Date:

Connect with a study center

  • Kanto Region

    Kanto,
    Japan

    Site Not Available

  • Kyushu Region

    Kyushu,
    Japan

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.